Thomas Dehmel

1.5k total citations
38 papers, 993 citations indexed

About

Thomas Dehmel is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pathology and Forensic Medicine. According to data from OpenAlex, Thomas Dehmel has authored 38 papers receiving a total of 993 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Thomas Dehmel's work include Multiple Sclerosis Research Studies (10 papers), Nerve injury and regeneration (8 papers) and Peripheral Neuropathies and Disorders (7 papers). Thomas Dehmel is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Nerve injury and regeneration (8 papers) and Peripheral Neuropathies and Disorders (7 papers). Thomas Dehmel collaborates with scholars based in Germany, United States and Switzerland. Thomas Dehmel's co-authors include Bernd C. Kieseier, Anne K. Mausberg, Hans‐Peter Hartung, Mark Stettner, Gerd Meyer zu Hörste, Jutta Gärtner, Verena I. Leussink, Heinz Wiendl, Clemens Warnke and Hans-Peter Hartung and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Neurology.

In The Last Decade

Thomas Dehmel

38 papers receiving 983 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Dehmel Germany 19 323 317 254 228 212 38 993
Stefanie Gaupp Germany 13 219 0.7× 205 0.6× 117 0.5× 146 0.6× 496 2.3× 17 1.0k
Jennifer L. Berard Canada 9 220 0.7× 238 0.8× 116 0.5× 100 0.4× 321 1.5× 9 929
Sharon A. Sagan United States 11 366 1.1× 269 0.8× 132 0.5× 69 0.3× 336 1.6× 17 906
Mariola Matysiak Poland 15 251 0.8× 265 0.8× 76 0.3× 70 0.3× 222 1.0× 34 825
Akira Sugimoto Japan 18 171 0.5× 424 1.3× 52 0.2× 283 1.2× 274 1.3× 61 1.3k
Gema Robledo Spain 17 82 0.3× 363 1.1× 77 0.3× 137 0.6× 260 1.2× 36 871
Pearl S. Rosenbaum United States 18 159 0.5× 740 2.3× 90 0.4× 196 0.9× 89 0.4× 34 1.4k
Ralf Gold Germany 13 544 1.7× 315 1.0× 161 0.6× 140 0.6× 773 3.6× 26 1.5k
Xiaobo Sun China 19 386 1.2× 291 0.9× 411 1.6× 50 0.2× 200 0.9× 59 954
André Ortlieb Guerreiro‐Cacais Sweden 17 307 1.0× 338 1.1× 85 0.3× 72 0.3× 513 2.4× 30 1.3k

Countries citing papers authored by Thomas Dehmel

Since Specialization
Citations

This map shows the geographic impact of Thomas Dehmel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Dehmel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Dehmel more than expected).

Fields of papers citing papers by Thomas Dehmel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Dehmel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Dehmel. The network helps show where Thomas Dehmel may publish in the future.

Co-authorship network of co-authors of Thomas Dehmel

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Dehmel. A scholar is included among the top collaborators of Thomas Dehmel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Dehmel. Thomas Dehmel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dehmel, Thomas, Norman Putzki, Bernd C. Kieseier, et al.. (2017). Cellular composition of peripheral blood mononuclear cells during 4 years long-term treatment with fingolimod (P5.364). Neurology. 88(16_supplement). 2 indexed citations
2.
Kim, Suhyun, Jae‐Won Hyun, In Hye Jeong, et al.. (2015). Anti-JC virus antibodies in rituximab-treated patients with neuromyelitis optica spectrum disorder. Journal of Neurology. 262(3). 696–700. 10 indexed citations
3.
Ingwersen, Jens, Til Menge, Britta Wingerath, et al.. (2014). Natalizumab restores aberrant miRNAexpression profile in multiple sclerosis and reveals a critical role for miR‐20b. Annals of Clinical and Translational Neurology. 2(1). 43–55. 68 indexed citations
4.
Stettner, Mark, et al.. (2014). Interleukin-17 impedes Schwann cell-mediated myelination. Journal of Neuroinflammation. 11(1). 63–63. 27 indexed citations
5.
Stettner, Mark, Anne K. Mausberg, Christian Wolf, et al.. (2013). A reliable in vitro model for studying peripheral nerve myelination in mouse. Journal of Neuroscience Methods. 214(1). 69–79. 18 indexed citations
6.
Dehmel, Thomas, Mark Stettner, David Kremer, et al.. (2013). Citalopram suppresses thymocyte cytokine production. Journal of Neuroimmunology. 262(1-2). 46–52. 20 indexed citations
7.
Stettner, Mark, Anne K. Mausberg, Philipp Albrecht, et al.. (2013). Promoting Myelination in an In Vitro Mouse Model of the Peripheral Nerve System: The Effect of Wine Ingredients. PLoS ONE. 8(6). e66079–e66079. 16 indexed citations
8.
Dehmel, Thomas, et al.. (2012). Ex vivo activation of naturally occurring IL-17-producing T cells does not require IL-6. Cytokine. 58(2). 231–237. 5 indexed citations
9.
Stettner, Mark, et al.. (2012). Fingolimod Impedes Schwann Cell–Mediated Myelination. Archives of Neurology. 69(10). 1280–9. 17 indexed citations
10.
Kieseier, Bernd C., Olaf Stüve, Thomas Dehmel, et al.. (2012). Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica. JAMA Neurology. 70(3). 390–390. 106 indexed citations
11.
Stettner, Mark, et al.. (2011). Levetiracetam exhibits protective properties on rat Schwann cells in vitro. Journal of the Peripheral Nervous System. 16(3). 250–260. 36 indexed citations
12.
Mausberg, Anne K., Gerd Meyer zu Hörste, Thomas Dehmel, et al.. (2011). Erythropoietin Ameliorates Rat Experimental Autoimmune Neuritis by Inducing Transforming Growth Factor-Beta in Macrophages. PLoS ONE. 6(10). e26280–e26280. 31 indexed citations
13.
Leussink, Verena I., et al.. (2009). Cladribine impedesin vitromigration of mononuclear cells: a possible implication for treating multiple sclerosis. European Journal of Neurology. 16(3). 409–412. 36 indexed citations
14.
Dehmel, Thomas, Hans H. Goebel, Hans‐Peter Hartung, et al.. (2008). The metalloproteinase‐disintegrin ADAM10 is exclusively expressed by type I muscle fibers. Muscle & Nerve. 38(2). 1049–1051. 3 indexed citations
15.
Lehmann, Helmar C., Gerd Meyer zu Hörste, Thomas Dehmel, et al.. (2007). Role of Nitric Oxide as Mediator of Nerve Injury in Inflammatory Neuropathies. Journal of Neuropathology & Experimental Neurology. 66(4). 305–312. 27 indexed citations
16.
Dehmel, Thomas, et al.. (2007). The cell-specific expression of metalloproteinase-disintegrins (ADAMs) in inflammatory myopathies. Neurobiology of Disease. 25(3). 665–674. 32 indexed citations
17.
Dehmel, Thomas, et al.. (2006). Inhibition by Mitoxantrone of In Vitro Migration of Immunocompetent Cells. Archives of Neurology. 63(11). 1572–1572. 33 indexed citations
18.
Hu, Wei, Thomas Dehmel, Jaana Pirhonen, Hans‐Peter Hartung, & Bernd C. Kieseier. (2006). Interleukin 23 in Acute Inflammatory Demyelination of the Peripheral Nerve. Archives of Neurology. 63(6). 858–858. 17 indexed citations
19.
Dehmel, Thomas, et al.. (2002). Two Different Targeting Signals Direct Human Peroxisomal Membrane Protein 22 to Peroxisomes. Journal of Biological Chemistry. 277(1). 774–784. 56 indexed citations
20.
Gärtner, Jutta, et al.. (2002). FUNCTIONAL CHARACTERIZATION OF THE ADRENOLEUKODYSTROPHY PROTEIN (ALDP) AND DISEASE PATHOGENESIS. Endocrine Research. 28(4). 741–748. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefanie Gaupp Breakdown of academic impact, for papers by Jennifer L. Berard Breakdown of academic impact, for papers by Sharon A. Sagan Breakdown of academic impact, for papers by Mariola Matysiak Breakdown of academic impact, for papers by Akira Sugimoto Breakdown of academic impact, for papers by Gema Robledo Breakdown of academic impact, for papers by Pearl S. Rosenbaum Breakdown of academic impact, for papers by Ralf Gold Breakdown of academic impact, for papers by Xiaobo Sun Breakdown of academic impact, for papers by André Ortlieb Guerreiro‐Cacais
Rankless by CCL
2026